Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices (2008)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1016/j.ab.2007.11.020
- Subjects: METALOPROTEINASES; LEUCEMIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Analytical Biochemistry
- ISSN: 0003-2697
- Volume/Número/Paginação/Ano: v. 374, n. 1, p. 56-63, 2008
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
MANNELLO, Ferdinando et al. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, v. 374, n. 1, p. 56-63, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.ab.2007.11.020. Acesso em: 18 mar. 2026. -
APA
Mannello, F., Tanus-Santos, J. E., Meschiari, C. A., & Tonti, G. A. (2008). Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices. Analytical Biochemistry, 374( 1), 56-63. doi:10.1016/j.ab.2007.11.020 -
NLM
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2026 mar. 18 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020 -
Vancouver
Mannello F, Tanus-Santos JE, Meschiari CA, Tonti GA. Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices [Internet]. Analytical Biochemistry. 2008 ; 374( 1): 56-63.[citado 2026 mar. 18 ] Available from: https://doi.org/10.1016/j.ab.2007.11.020 - Xanthine oxidoreductase contributes to vasodillation and antihypertensive effects of sodium nitrite in renovascular hypertension
- L-arginina atenua a hipertensão pulmonar decorrente de embolia pulmonar aguda
- Elevated plasma hemoglobin levels increase nitric oxide consumption in experimental and clinical acute pulmonary thromboembolism
- eNOS polymorphism associated with metabolic syndrome in children and adolescents
- Vascular damage in resistant hypertension: TNF-alpha inhibition effects on endothelial cells
- Adiponectin -11377C/G and +276G/T polymorphisms affect adiponectin levels but not modify responsiveness to therapy in resistant hypertension
- Isoflavone genistein inhibits the angiotensin-converting enzyme and alters the vascular responses to angiotensin I and bradykinin
- Estresse oxidativo prejudica o efeito vasodilatador do nitrito de sódio mediado pela xantina oxidoredutase na hipertensão renovascular
- A metaloproteinase da matriz-2 (MMP-2) contribui para a disfunção vascular da hipertensão renovascular
- Atorvastatina reduz a hipertensão arterial pulmonar causada por embolia pulmonar aguda (EPA) em ratos
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
